Fortitude Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Fortitude Advisory Group's PFE Position: Q3 2026 in Review
Fortitude Advisory Group reduced its Pfizer (PFE) stake by 6.2% in Q3 2026, selling an estimated $16.1K and leaving 9,095 shares worth $259K. The position accounts for 0.1% of the portfolio, ranked #188.
Fortitude Advisory Group first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.17M in Q4 2021. 1,752 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Fortitude Advisory Group held 9,095 shares of Pfizer worth $259K as of Q3 2026.
- Fortitude Advisory Group sold 605 Pfizer shares in Q3 2026, an estimated $16.1K.
- Pfizer made up 0.1% of Fortitude Advisory Group's portfolio in Q3 2026, its #188 holding.
- Fortitude Advisory Group first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- Fortitude Advisory Group's Pfizer position peaked at $1.17M in Q4 2021.
- 1,752 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Fortitude Advisory Group's 13F filing for Q3 2026, filed 15 Oct 2026.